|
1
|
Scolozzi P, Bosson G and Jaques B: Severe
isolated temporomandibular joint involvement in juvenile idiopathic
arthritis. J Oral Maxillofac Surg. 63:1368–1371. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin YC, Hsu ML, Yang JS, Liang TH, Chou SL
and Lin HY: Temporomandibular joint disorders in patients with
rheumatoid arthritis. J Chin Med Assoc. 70:527–534. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Helenius LM, Tervahartiala P, Helenius I,
et al: Clinical, radiographic and MRI findings of the
temporomandibular joint in patients with different rheumatic
diseases. Int J Oral Maxillofac Surg. 35:983–989. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Narváez JA, Narváez J, Roca Y and Aguilera
C: MR imaging assessment of clinical problems in rheumatoid
arthritis. Eur Radiol. 12:1819–1828. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Quinn JH: Arthroscopic and histologic
evidence of chondromalacia in the temporomandibular joint. Oral
Surg Oral Med Oral Pathol. 70:387–392. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kapila S, Lee C, Tavakkoli Jou MR, Miller
AJ and Richards AW: Development and histologic characterizations of
an animal model of antigen-induced arthritis of the juvenile rabbit
temporomandibular joint. J Dent Res. 74:1870–1879. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Horton MA, Lewis D, McNulty K, Pringle JA
and Chambers TJ: Monoclonal antibodies to osteoclastomas (giant
cell bone tumors): Definition of osteoclast-specific cellular
antigens. Cancer Res. 45:5663–5669. 1985.PubMed/NCBI
|
|
8
|
Quinn JM, Morfis M, Lam MH, et al:
Calcitonin receptor antibodies in the identification of
osteoclasts. Bone. 25:1–8. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roodman GD: Advances in bone biology: The
osteoclast. Endocr Rev. 17:308–332. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Romas E, Bakharevski O, Hards DK,
Kartsogiannis V, Quinn JM, Ryan PF, Martin TJ and Gillespie MT:
Expression of osteoclast differentiation factor at sites of bone
erosion in collagen-induced arthritis. Arthritis Rheum. 43:821–826.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hofbauer LC and Heufelder AE: Role of
receptor activator of nuclear factor-kappaB ligand and
osteoprotegerin in bone cell biology. J Mol Med (Berl). 79:243–253.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ohazama A, Courtney JM and Sharpe PT: Opg,
Rank and Rankl in tooth development: Co-ordination of odontogenesis
and osteogenesis. J Dent Res. 83:241–244. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wakita T, Mogi M, Kurita K, Kuzushima M
and Togari A: Increase in RANKL: OPG ratio in synovia of patients
with temporomandibular joint disorder. J Dent Res. 85:627–632.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Haynes DRI, Crotti TN, Loric M, Bain GI,
Atkins GJ and Findlay DM: Osteoprotegerin and receptor activator of
nuclear factor kappaB ligand (RANKL) regulate osteoclast formation
bycells in the human rheumatoid arthritic joint. Rheumatology
(Oxford). 40:623–630. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Geusens PP, Landewé RB, Garnero P, et al:
The ratio of circulating osteoprotegerin to RANKL in early
rheumatoid arthritis predicts later joint destruction. Arthritis
Rheum. 54:1772–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martínez-Calatrava MJ, Prieto-Potín I,
Roman-Blas JA, Tardio L, Largo R and Herrero-Beaumont G: RANKL
synthesized by articular chondrocytes contributes to
juxta-articular bone loss in chronic arthritis. Arthritis Res Ther.
18:R1492012. View
Article : Google Scholar
|
|
17
|
Brand DD, Latham KA and Rosloniec EF:
Collagen-induced arthritis. Nat Protoc. 2:1269–1275. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hirota Y, Habu M, Tominaga K, et al:
Relationship between TNF-alpha and TUNEL-positive chondrocytes in
antigen-induced arthritis of the rabbit temporomandibular joint. J
Oral Pathol Med. 35:91–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matsukawa A, Ohkawara S, Maeda T, Takagi K
and Yoshinaga M: Production of IL-1 and IL-1 receptor antagonist
and the pathological significance in lipopolysaccharide-induced
arthritis in rabbits. Clin Exp Immunol. 93:206–211. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Grimaud E, Soubigou L, Couillaud S, et al:
Receptor activator of nuclear factor kappaB ligand
(RANKL)/osteoprotegerin (OPG) ratio is increased in severe
osteolysis. Am J Pathol. 163:2021–2031. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gravallese EM, Harada Y, Wang JT, Gorn AH,
Thornhill TS and Goldring SR: Identification of cell types
responsible for bone resorption in rheumatoid arthritis and
juvenile rheumatoid arthritis. Am J Pathol. 152:943–951.
1998.PubMed/NCBI
|
|
22
|
Kuruvilla AP, Shah R, Hochwald GM, Liggitt
HD, Palladino MA and Thorbecke GJ: Protective effect of
transforming growth factor beta 1 on experimental autoimmune
diseases in mice. Proc Natl Acad Sci USA. 88:2918–2921. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Holmdahl R, Jansson L, Andersson M and
Jonsson R: Genetic, hormonal and behavioural influence on
spontaneously developing arthritis in normal mice. Clin Exp
Immunol. 88:467–472. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boyce BF and Xing L: Functions of
RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem
Biophys. 473:139–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kwan Tat S, Padrines M, Théoleyre S,
Heymann D and Fortun Y: IL-6, RANKL, TNF-alpha/IL-1: Interrelations
in bone resorption pathophysiology. Cytokine Growth Factor Rev.
15:49–60. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tominaga K, Alstergren P, Kurita H,
Matsukawa A, Fukuda J and Kopp S: Interleukin-1beta in
antigen-induced arthritis of the rabbit temporomandibular joint.
Arch Oral Biol. 46:539–544. 2001. View Article : Google Scholar : PubMed/NCBI
|
